1. Brickner SJ (1996) Oxazolidinone antibacterial agents. Curr Pharm Des 2(2):175–194
2. Barbachyn MR, Brickner SJ, Hutchinson DK (1997) Substituted oxazine and thiazine oxazolidinone antimicrobials. US Patent 5,688,792, A1
3. U.S. Food and Drug Administration. Zyvox (Linezolid) Tablets, Injection & Oral Suspension. Application No 021130s003, 021131s003 & 021132s003. Approval Date 12/19/2002. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-130s003_21131s003_21132s003_ZyvoxTOC.cfm
4. Slee A, Wuonola M, McRipley R, Zajac I, Zawada M, Bartholomew P, Gregory W, Forbes M (1987) Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721. Antimicrob Agents Chemother 31(11):1791–1797
5. Eustice D, Feldman P, Slee A (1988) The mechanism of action of dup 721, a new antibacterial agent: effects on macromolecular synthesis. Biochem Biophys Res Commun 150(3):965–971